Cell Sciences News Today

According to the Market Statsville Group (MSG), the global reverse transcriptase enzyme market size is expected to grow at a CAGR of 3.4% from 2022 to 2030.

Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The

Scientists at the Pune-based National Centre for Cell Sciences have claimed to have identified two bacteria in the small intestine that can break gluten, to cure Celiac disease, an immune reaction to eating gluten, a protein found mostly in wheat, barley, and rye. Also known as celiac sprue or gluten-sensitive enteropathy, this condition triggers an instant immune response in the small intestine after eating gluten which damages the lining and prevents it from absorbing nutrients. The disease pr...

Gokhale has worked extensively on tuberculosis and is credited to have developed the Long-chain Fatty acyl-AMP ligases (FAAL).

A polypeptide known as human epidermal growth factor (EGF) binds to the receptor EGFR, which triggers a series of reactions that activate gene pathways

/PRNewswire/ -- The "Global Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, Rapid Test, Western Blotting, ELISPOT), Specimen...

PUNE, India, Aug. 30, 2022 /PRNewswire/ -- The global immunoassay market is valued at an estimated USD 40.2 billion in 2022 and is projected to reach USD 49.6 billion by 2027, at a CAGR of 4.3%

In a recent study published in the journal ACS Applied Bio Materials, researchers demonstrated the inhibitory potential of curcumin-encapsulated polysaccharide nanoparticles (CUR−PS-NPs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (CoV2-SP)-stimulated cytokine storm in lung and liver epithelial cells.

Read more about India Coronavirus Dispatch: Bihar worst performer on vaccination coverage on Business Standard. Delta variant now in 174 districts across the country, govt is developing two new testing labs for vaccines, more-news relevant to Indias fight against the pandemic

Share this article Share this article ResearchAndMarkets.coms offering. The global immunoassay market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions. Emerging markets in Asian countries are expected to offer strong growth opportunities for players i...